📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. (2021)

First Author: Roddie C

Attributed to: Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.00917

PubMed Identifier: 34464155

Publication URI: http://europepmc.org/abstract/MED/34464155

Type: Journal Article/Review

Volume: 39

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 30

ISSN: 0732-183X